You can buy or sell DMPI and other stocks, options, ETFs, and crypto commission-free!
DelMar Pharmaceuticals, Inc. Common Stock, also called DelMar Pharmaceuticals, is a clinical and commercial stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. Read More It offers VAL-083; drug discovery research; as well as patents and intellectual property. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in Vancouver, Canada.
Vancouver, British Columbia
52 Week High
52 Week Low
Research And Development
Seeking AlphaMay 23
DelMar Pharmaceuticals, Inc. CEO Saiid Zarrabian on Q3 2019 Results - Earnings Call Transcript
DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) Q3 2019 Earnings Conference Call May 23, 2019 4:30 PM ET Company Participants Saiid Zarrabian - President & Chief Executive Officer Scott Praill - Chief Financial Officer Greg Johnson - Head of Clinical & Operations Conference Call Participants Operator Thank you all for joining us this afternoon for the DelMar Pharmaceuticals Quarterly Call and Webcast to discuss the Company's Financial Results for the Third Quarter of the 2019 Fiscal Year Ending June 30, 2...
-$0.67 per share